Key Takeaways
- Artificial intelligence is being studied as a tool to help diagnose mesothelioma, predict outcomes, and speed up drug discovery.
- Mesothelioma is usually diagnosed through symptoms, asbestos exposure history, imaging, and a biopsy. AI is being researched to help doctors analyze scans and tissue samples.
- In 2024, an AI-designed drug candidate for mesothelioma, ISM6331, was cleared by the FDA to begin clinical trials. It is not yet an approved treatment.
- AI can analyze large amounts of research data far faster than people, which may help researchers identify promising treatments sooner.
- AI supports doctors and researchers. It does not replace diagnosis or treatment by a mesothelioma specialist.
- Mesothelioma is caused by asbestos exposure, and patients and families may be entitled to compensation. Call 800-505-6000 for a free case review.
What is mesothelioma and how is it typically diagnosed?
Mesothelioma is a type of cancer that typically develops due to asbestos exposure. Asbestos was widely used for its fireproofing and durable properties. When asbestos’ sharp microscopic fibers are inhaled, they can embed themselves into organ tissue lining. Eventually, this can develop into mesothelioma, asbestosis, lung cancer, or another asbestos-related disease. Keep reading to learn more about mesothelioma and artificial intelligence.
Mesothelioma is typically diagnosed by taking a look at a patient’s symptoms, work history for potential asbestos exposure, medical imaging, and a series of tests. Symptoms of mesothelioma include:
- Shortness of breath
- Trouble breathing
- Persistent cough
- Abdominal pain
- Fatigue
- Unexplained weight loss
- Heart murmur
Experienced. Dedicated. Proven. We fight for Mesothelioma Victims.
Find Out If You Qualify for Compensation
With over 35 years of experience, the Halpern Law Firm is ready to fight for you. Get a free, no-obligation case review today and take the first step toward the compensation you deserve.
Applications for artificial intelligence in medical technology
Artificial intelligence is moving through many different industries. Its applications are widespread, particularly in medical technology. AI can diagnose mesothelioma sooner, giving the victim a better chance of survival and better outcome for treatment.
A biotech company recently developed new FDA-approved drugs to treat mesothelioma using artificial intelligence. This biotech company’s AI generated potential compound groups to get the development of the drug started. In other words, the AI told drug researchers potential “recipes” for an effective treatment. The AI was also able to assess the combination of these “ingredients,” optimizing the combinations. The AI was taught to consider human safety and health, so it did not put together compounds that would cause harm if ingested.
The AI was also able to predict potential side effects and behavior of the drug before clinical trials.
Artificial intelligence can also take existing mesothelioma cancer cell data and process it. AI can make predictions and make conclusions off the data that would take a researcher months or years to complete.
If you or a loved one have been diagnosed with mesothelioma or another asbestos-related disease, you may be eligible for financial compensation. The experienced team at the Halpern Law Firm can help you through every step of the process; from filing a claim to receiving your settlement. For a free consultation, call (800) 505-6000 or fill out our contact form.
Frequently Asked Questions
How is artificial intelligence being used in mesothelioma research?
Researchers are using AI to analyze CT scans and biopsy slides, predict how a patient’s cancer may progress, and identify new drug compounds. These tools can process large amounts of data quickly and spot patterns that may be difficult for people to see.
Can AI diagnose mesothelioma?
AI is not used on its own to diagnose mesothelioma. A diagnosis still requires a doctor’s evaluation, imaging, and a biopsy reviewed by a pathologist. Researchers are studying whether AI can help pathologists distinguish mesothelioma from other conditions and help radiologists measure tumors more accurately.
Is there an FDA-approved mesothelioma drug developed with AI?
An AI-designed drug candidate for mesothelioma, ISM6331, received FDA clearance in 2024 to begin human clinical trials. Clearance to start trials is not the same as FDA approval. The drug must still show it is safe and effective in clinical studies before it can be approved for patients.
Can AI predict mesothelioma survival?
Some research models have used AI to analyze tissue samples and predict patient outcomes, in some cases identifying features linked to survival that pathologists had not previously used. These tools are still mainly used in research and are not a substitute for a prognosis from your medical team.
Could AI help detect mesothelioma earlier?
Researchers hope AI will help identify signs of mesothelioma earlier on imaging, especially in people with known asbestos exposure. Earlier detection can open up more treatment options. If you have a history of asbestos exposure, tell your doctor so they can watch for related symptoms.
How can I access new mesothelioma treatments being developed?
Clinical trials are the main way patients access new treatments before approval. Ask your oncologist about trials you may qualify for, or search ClinicalTrials.gov. Major cancer centers that specialize in mesothelioma often run or participate in these studies.
Can a mesothelioma claim help cover treatment costs?
People diagnosed with mesothelioma after asbestos exposure may be entitled to compensation through lawsuits and asbestos trust funds, which can help pay for treatment, travel to specialty centers or clinical trials, lost income, and other costs. Call The Halpern Law Firm at 800-505-6000 for a free case review.